02/26/2020
https://congress.gov...
"Passage of the Compounding Quality act was about patient safety."
"Compounded drug products are not reviewed by FDA prior to coming to the market for safety and effectiveness."
"I want to thank my colleagues Congressman Griffith and Congresswoman DeGette because we worked together on a bipartisan basis to solve this problem."
"Yet despite this rare consensus, Republicans on this committee have decided to unveil a series of partisan bills that don't address the real problems."